Dxcover Ltd joins in recognizing July 17 2024 as #GBMDay in the US Company establishing US operations in Nashville TN…
May 29, 2024 GLASGOW, Scotland–Dxcover Limited, a clinical-stage diagnostics company pioneering its multi-omic spectral analysis (MOSA) for early detection of…
May 13, 2024 | GLASGOW, Scotland Dxcover Limited, a clinical-stage diagnostics company pioneering its multi-omic spectral analysis (MOSA) for early…
Dxcover invited to present its CREATE-2 clinical trial for the early detection of colorectal cancer and advanced adenoma at the…
5th Feburary 2024 Glasgow-based Dxcover Ltd. are developing a diagnostic tool to detect brain tumours, and they are one of…
The trials will utilize the Dxcover Liquid Biopsy Test to detect cancer at its earliest signs Glasgow, Scotland, January 9,…
Prof. Matthew Baker to present data on detection of early-stage tumors across multiple cancers. Glasgow, Scotland, December 20, 2023 …
Founder and CTO Prof. Matthew Baker named Chief Executive Officer Chief Data Scientist Dr David Palmer named Chief Technical Officer…
CEO, Mark Hegarty, and CTO, Matthew Baker, were recently interviewed by 360Dx about Dxcover’s ground breaking blood test for Brain…
Prize awarded in the Innovative Diagnostics Tools category supporting the groundbreaking potential of the Dxcover Multi-Omic Spectral Analysis in Early…
Benefits of the multi-omic spectral analysis approach highlight the significant potential of the Dxcover Platform for early detection of cancer.…
Ron Andrews Joins Company as Non-Executive Chair Stacy Chick Named US Commercial & Business Development Advisor and Stuart McRoberts Named…
Rapid blood test sensitive to advanced adenomas could improve patient prognosis and ultimately reduce mortality. Dxcover Limited, a clinical-stage diagnostics…
Enables CE Marking of blood test for brain cancer and advances colorectal cancer development. Glasgow, Scotland, February 1, 2023 Dxcover…
Grant enables pivotal multi-centre study for CE Marking of Dxcover Brain Cancer Liquid Biopsy. Dxcover Limited, a clinical stage diagnostics…
Study published in Cancers demonstrates how simple, minimally invasive and accurate approaches can represent a powerful aid in earlier detection…
Dublin, Ireland June 20, 2022 Dxcover Limited, a diagnostics company developing spectroscopic liquid biopsy technology for early detection of multiple…
Dxcover test could have a significant impact on early detection of cancer, vital for improved survival and quality of life…
Dxcover Limited, a clinical stage diagnostics company developing its spectroscopic biopsy technology for early detection of multiple cancers, today announced…
Data highlight high sensitivity of novel infrared spectroscopy approach for stage I disease SCOTLAND, UK., March 29, 2022 Dxcover Limited,…
Cancer diagnostics company, Dxcover Limited, has published its latest data from clinical studies on earlier detection of aggressive cancers. The…
Dxcover Limited, developer of liquid biopsies for the early detection of cancer, has secured US patents for its groundbreaking Dxcover®…
Dxcover Limited, developer of liquid biopsies for the early detection of cancer, has secured ISO 13485:2016 certification for its Quality…
An editorial article from SelectScience was published on 26th January 2022, with an interview with Dxcover CEO Mark Hegarty. The…
Dxcover® are delighted to announce the appointment of Dr Paul Brennan to their Scientific Advisory Board (SAB). Dr Brennan is…
· Blood test proves ability to identify really small brain tumours and gives hope of earlier detection and improved survival…
We were delighted to speak to Health Tech World recently about the future of cancer diagnostics. “Hailed as the future…
Dxcover Limited has appointed experienced diagnostics industry professional Dr David Eustace as Operations Director to drive product development, manufacturing, regulatory…
Luke Pike MD, DPhil, Radiation Oncologist, joins Dxcover Scientific Advisory Board to advise the company on brain cancer diagnostic early…
ClinSpec Diagnostics Limited (ClinSpec Dx), the Glasgow-based developer of liquid biopsies for early detection of cancer, has reached its round…
Luke Pike MD, DPhil, Radiation Oncologist, joins Dxcover Scientific Advisory Board to advise the company on brain cancer diagnostic early…
The Tech Nation 2020 report on ‘UK Tech for a changing world’ was released this week, looking to overview the…
ClinSpec Diagnostics are delighted to announce that they were shortlisted as one of the top pioneering technology companies at 2020’s…
ClinSpec Diagnostics have been announced as one of the members of the first ever Tech Nation Applied AI cohort! …
A blood test which could help to accelerate the diagnosis of brain cancer has been developed in research led at…
We are pleased to announce that our base patent has been granted in the USA and the EU, covering our…
Clinspec Dx are crowned the winners of Scotland’s Life Sciences Innovation award! There are 7 prestigious awards acknowledging a range…
ClinSpec Diagnostics are delighted to announce the completion of seed investment to spin-out of the University of Strathclyde, following a…
Dr Holly Butler and Dr. Mark Hegarty had the pleasure of presenting to a panel at the Scottish Edge awards.…
ClinSpec Dx™ were the recipients of the Moonshot award at the Global Game Changers, which rewards businesses that are striving…
The international SPEC 2018 conference was held in Glasgow at the Technology and Innovation Centre from the 10-15th of June.…
Insider.co.uk this week revealed their latest installment of “20 women to watch in Scotland in 2018”, and named a ClinSpec…
Dr Holly Butler of ClinSpec Dx pitched at 2018’s prestigious Engage, Invest, Exploit (EIE) event, held at the McEwan Hall,…
An early health economic assessment of a spectroscopic blood test for the early detection of brain tumours conducted by members…
Inventor and Chief Science Officer, Dr Matthew Baker was placed on the top 40 under 40 ran by The Analytical…
The ClinSpec Dx Triage ID system is now installed at Western General Hospital in Edinburgh, to undergo a new clinical…
Autumn was a busy season for ClinSpec Dx; with the Converge Challenge Finals looming, there were also some personal successes…
The Converge Challenge second place prize was awarded to Dr Holly Butler of University of Strathclyde with ClinSpec…
The SPEC2018 Conference will take place in the Technology and Innovation Centre of the University of Strathclyde from 10th -…
Dr Holly J Butler wins first prize for ClinSpec Dx at the Converge Challenge awards 2017. Read all about it…
Benefits of the multi-omic spectral analysis approach highlight the significant potential of the Dxcover Platform for early detection of cancer.
Dxcover test could have a significant impact on early detection of cancer, vital for improved survival and quality of life.
Dxcover Limited, a clinical stage diagnostics company developing its spectroscopic biopsy technology for early detection of multiple cancers, today announced…
Data highlight high sensitivity of novel infrared spectroscopy approach for stage I disease SCOTLAND, UK., March 29, 2022 Dxcover Limited,…
Cancer diagnostics company, Dxcover Limited, has published its latest data from clinical studies on earlier detection of aggressive cancers. The…
Dxcover Limited, developer of liquid biopsies for the early detection of cancer, has secured US patents for its groundbreaking Dxcover®…
Dxcover Limited, developer of liquid biopsies for the early detection of cancer, has secured ISO 13485:2016 certification for its Quality…
An editorial article from SelectScience was published on 26th January 2022, with an interview with Dxcover CEO Mark Hegarty. The…
Dxcover® are delighted to announce the appointment of Dr Paul Brennan to their Scientific Advisory Board (SAB). Dr Brennan is…
· Blood test proves ability to identify really small brain tumours and gives hope of earlier detection and improved survival…
We were delighted to speak to Health Tech World recently about the future of cancer diagnostics. “Hailed as the future…
Dxcover Limited has appointed experienced diagnostics industry professional Dr David Eustace as Operations Director to drive product development, manufacturing, regulatory…
Luke Pike MD, DPhil, Radiation Oncologist, joins Dxcover Scientific Advisory Board to advise the company on brain cancer diagnostic early…
ClinSpec Diagnostics Limited (ClinSpec Dx), the Glasgow-based developer of liquid biopsies for early detection of cancer, has reached its round…
Luke Pike MD, DPhil, Radiation Oncologist, joins Dxcover Scientific Advisory Board to advise the company on brain cancer diagnostic early…
The Tech Nation 2020 report on ‘UK Tech for a changing world’ was released this week, looking to overview the…
ClinSpec Diagnostics are delighted to announce that they were shortlisted as one of the top pioneering technology companies at 2020’s…
ClinSpec Diagnostics have been announced as one of the members of the first ever Tech Nation Applied AI cohort! …
A blood test which could help to accelerate the diagnosis of brain cancer has been developed in research led at…
We are pleased to announce that our base patent has been granted in the USA and the EU, covering our…
Clinspec Dx are crowned the winners of Scotland’s Life Sciences Innovation award! There are 7 prestigious awards acknowledging a range…
ClinSpec Diagnostics are delighted to announce the completion of seed investment to spin-out of the University of Strathclyde, following a…
Dr Holly Butler and Dr. Mark Hegarty had the pleasure of presenting to a panel at the Scottish Edge awards.…
ClinSpec Dx™ were the recipients of the Moonshot award at the Global Game Changers, which rewards businesses that are striving…
The international SPEC 2018 conference was held in Glasgow at the Technology and Innovation Centre from the 10-15th of June.…
Insider.co.uk this week revealed their latest installment of “20 women to watch in Scotland in 2018”, and named a ClinSpec…
Dr Holly Butler of ClinSpec Dx pitched at 2018’s prestigious Engage, Invest, Exploit (EIE) event, held at the McEwan Hall,…
An early health economic assessment of a spectroscopic blood test for the early detection of brain tumours conducted by members…
Inventor and Chief Science Officer, Dr Matthew Baker was placed on the top 40 under 40 ran by The Analytical…
The ClinSpec Dx Triage ID system is now installed at Western General Hospital in Edinburgh, to undergo a new clinical…
Autumn was a busy season for ClinSpec Dx; with the Converge Challenge Finals looming, there were also some personal successes…
The Converge Challenge second place prize was awarded to Dr Holly Butler of University of Strathclyde with ClinSpec…
The SPEC2018 Conference will take place in the Technology and Innovation Centre of the University of Strathclyde from 10th -…
Dr Holly J Butler wins first prize for ClinSpec Dx at the Converge Challenge awards 2017. Read all about it…
Dxcover received the Medtech Breakthrough Award in 2025.
Dxcover received the ADLM Award.
Dxcover received the ESMO Award.
Dxcover was a winner at the Scottish Life Sciences 2019 awards.
Dxcover was recognized as Made in Scotland.
Dxcover was featured at Medica.